{"id":"W2613424814","doi":"10.1016/j.cct.2017.05.007","title":"The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis","year":2017,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Medicine; Exacerbation; Bronchiectasis; Placebo; Clinical endpoint; Ciprofloxacin; Dry-powder inhaler; Sputum; Randomization; Internal medicine; Inhalation; Randomized controlled trial; Cystic fibrosis; Intensive care medicine; Inhaler; Antibiotics; Lung; Anesthesia; Pathology; Tuberculosis; Microbiology; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3649646,0.0008605719,0.02335142,0.0006090307,0.0007581617,0.0004261693,0.001081973,0.0006796166,0.0002249964],"category_scores_gemma":[0.8622697,0.0004855747,0.006931445,0.0003453755,0.001563281,0.0007057626,0.0003017012,0.001013124,0.00002767868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001718612,"about_ca_system_score_gemma":0.001770977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004798429,"about_ca_topic_score_gemma":0.0001622758,"domain_scores_codex":[0.90738,0.05591456,0.03152136,0.001852932,0.001950968,0.001380208],"domain_scores_gemma":[0.3714046,0.6010219,0.02173672,0.003468881,0.001405534,0.0009622744],"domain_codex":null,"domain_gemma":"methods","domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.892087,0.001222118,0.001064975,0.000323945,0.002606725,0.00002971873,0.0001610764,0.00001763453,0.0175372,0.0001819957,0.005851424,0.0789162],"study_design_scores_gemma":[0.9666704,0.002177279,0.0006459977,0.001954194,0.002484108,0.000001296108,0.0003324489,0.009150205,0.008862531,0.002142317,0.005099313,0.0004799146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7360939,0.03995495,0.01944217,0.0184739,0.008544392,0.1712775,0.002106298,0.0002698076,0.003837119],"genre_scores_gemma":[0.9843977,0.00177007,0.003814818,0.00020239,0.002812918,0.005040198,0.0002214173,0.0001128891,0.001627581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5451074,"threshold_uncertainty_score":0.9997596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2641399374290532,"score_gpt":0.5397798439468302,"score_spread":0.275639906517777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}